Antiepileptic Drugs Market - Forecast(2021 - 2026)

Report Code: HCR 0142 Report Format: PDF + Excel (Delivery in 48 Hrs)

Antiepileptic Drugs Market Report Overview

Antiepileptic Drugs Market size in 2019 is estimated to be $ 3.45 billion, growing at a CAGR of 3.8% during the forecast period 2020-2025. Antiepileptic drug can also be known as anti-seizure drug, developed for asymptomatic and Idiopathic treatment of epilepsy and seizures. Antiepileptic drugs can also be used for the treatment of neuropathic pain. Therapeutic Drug Monitoring can usually applied to optimize the treatment of epilepsy.  Increasing incidence of neurological disorder and advancement in drugs modification are the major factors driving the growth of the market. Moreover, changing lifestyle, alcoholism, rising geriatric population and active government support and investment further enhance the overall market demand for Antiepileptic Drugs during the forecast period 2020-2025.

Report Coverage

The report: “Antiepileptic Drugs Market – Forecast (2020-2025)”, by IndustryARC, covers an in-depth analysis of the following segments of the Antiepileptic Drugs Market:
By Drug Type : First Generation Drugs, Second Generation Drugs, Pipeline Drugs 
By Route of Administration : Oral, Intravenous
By Spectrum Type : Narrow Spectrum, Broad Spectrum
By Distribution Channel : Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Geography: North America, Europe, Asia-Pacific, and Rest of the World

Key Takeaways

  • In 2019, North America dominates the Antiepileptic Drugs Market owing to increasing prevalence of epilepsy and launches of generic drug and increasing social awareness, social acceptance, and awareness among the population.
  • Increasing incidence of neurological disorder and advancement in drugs modification is driving the market growth of antiepileptic drugs.
  • Detailed analysis of the Strength, Weakness, and opportunities of the prominent players operating in the market will be provided in the Antiepileptic Drugs Market report.
  • Rise in medical supply shortage and increasing side effects are challenging the growth of the market. 

Drug Type - Segment Analysis

Based on the Drug Type, Antiepileptic Drugs Market is segmented into First Generation Drugs, Second Generation Drugs and Pipeline Drugs. The second generation drugs segment is forecast to be the fastest-growing segment and is projected to grow at a CAGR of 2.8% during the forecast period 2020-2025. Second Generation Drugs has been the blockbuster drug for epilepsy treatment and has proved its potential in slowing the impulses of the brain and controlling the seizures. Moreover, it has effective drug structure and its usage in most types of seizures that are contributing to the growth of this segment.

Distribution Channel - Segment Analysis

Based on the Distribution Channel, Antiepileptic Drugs Market is segmented into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. In 2019, hospital pharmacies held the largest share in the Antiepileptic Drugs Market. This is mainly owing to increasing number of patients suffering from conditions which are treated in hospitals equipped with advanced infrastructure and adequate facilities. Moreover, growing number of hospitals along with adequate reimbursement policies is also contributing to the growth of this segment.

Geography - Segment Analysis

North America dominated the Antiepileptic Drugs Market share accounting for 46% of the market in 2019. This is mainly owing to increasing prevalence of epilepsy and launches of generic drug and increasing social awareness, social acceptance, and awareness among the population. According to Centers for Disease Control and Prevention, about 3.4 million people are suffering from active epilepsy in the U.S., where 3 million adults and 470,000 children.
However, the Asia-Pacific region is projected to be the fastest-growing during the forecast period 2020-2025. This is owing to increasing awareness among people about health and developing healthcare infrastructure.

Drivers – Antiepileptic Drugs Market 

  • Increasing Incidence of Neurological Disorder

Increasing incidence of neurological disorder and rising geriatric population are some factors driving the growth of Antiepileptic Drugs Market. According to World Health Organization, millions of people are suffering from neurological disorders  and about 50 million people are suffering from epilepsy which is a common serious brain disorder is also set to increase the market growth. 

  • Advancement in Drug Modification

Increasing advancement of drug modification and increasing number of available Antiepileptic drugs are some factors driving the growth of the market. Moreover, advancement in drugs provide small effects on liver metabolism that converts into a lower rate of side effects further contributing to the growth of Antiepileptic Drugs Market.

Challenges – Antiepileptic Drugs Market 

Rise in medical supply shortage and increasing side effects are challenging the growth of the market. Moreover, patients are stockpiling the medicines as there is a shortage of drugs in the pharmacies are further restraining its market growth during the forecast period 2020-2025.

Antiepileptic Drugs Industry Outlook

  • Product launches, Merger & Acquisitions, joint ventures and R&D activities are key strategies adopted by players in the Antiepileptic Drugs Market. Antiepileptic drugs top 10 companies are Sanofi, Pfizer Inc., GW Pharmaceutical plc., UCB S.A., Eisai Co. Ltd., Sunovion Pharmaceuticals Inc., Lundbeck A/S, and GlaxoSmithKline plc.

Acquisitions/Product Launches:

  • On September 2019, GW Pharmaceuticals plc. Launches new innovative drugs, EPIDYOLEX that are used for Dravet syndrome or Lennox Gastaut syndrome (LGS), as an adjunctive therapy of seizures.
  • On January 2020, Eisai Co. Ltd. Launches new drug FYCOMPA for the treatment of partial-onset seizures in patients aged 12 years and older.
1. Antiepileptic Drugs Market Overview
    1.1 Definitions and Scope
2. Antiepileptic Drugs Market Executive Summary
    2.1 Market Revenue, Market Size and Key Trends 
    2.2 Key trends by Drug Type
    2.3 Key trends by Route of Administration
    2.4 Key trends by Spectrum Type
    2.5 Key trends by Distribution Channel
    2.6 Key trends by Geography
3. Antiepileptic Drugs Market Landscape
    3.1 Market Share Analysis- Key Companies
    3.2 Product Benchmarking- Key Companies
    3.3 Financial Analysis - Key Companies
    3.4 Patent Analysis 
    3.5 Pricing Analysis
4. Antiepileptic Drugs Market - Startup companies Scenario Premium Premium
    4.1 Key startup company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Application Analysis
        4.1.4 Venture Capital and Funding Scenario
5. Antiepileptic Drugs Market - Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of successful ventures
6. Antiepileptic Drugs Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters Five Force Model
        6.3.1 Bargaining Power of Suppliers
        6.3.2 Bargaining Powers of Customers
        6.3.3 Threat of New Entrants
        6.3.4 Rivalry Among Existing Players
        6.3.5 Threat of Substitutes 
7. Antiepileptic Drugs Market Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Antiepileptic Drugs Market – By Drug Type (Market Size -$Million/$Billion)
    8.1 First Generation Drugs
        8.1.1 Valproate (Depakote)
        8.1.2 Oxycarbazepine ((Trileptal)
        8.1.3 Carbamazepine (Carbatrol)
        8.1.4 Phenobarbital (Luminal)
        8.1.5 Primidone (Mysoline)
        8.1.6 Ethosuximide (Zarontin)
        8.1.7 Topiramate (Topamax)
    8.2 Second Generation Drugs
        8.2.1 Lamotrigine (Lamictal)
        8.2.2 Pregabalin (Lyrica)
        8.2.3 Eslicarbazepine acetate Zonisamide (Zonegran)
        8.2.4 Lacosamide (Vimpat)
        8.2.5 Levetiracetam (Keppra)
        8.2.6 (Aptiom/Zebinix) 
        8.2.7 Perampanel (Fycompa)
        8.2.8 Rufinamide (Banzel/Inovelon)
        8.2.9 Ezogabine/retigabine (Trobalt/Potiga)
    8.3 Pipeline Drugs
        8.3.1 Buspirone
        8.3.2 Everoline
        8.3.3 UCB0942 (PPSI)
        8.3.4 Lacosamide
        8.3.5 GWP42006
        8.3.6 TAK-932
        8.3.7 Brivaracetam (UCB Pharma Ltd)
        8.3.8 Ganaxolone (Marinus Pharmaceuticals)
        8.3.9 USL261 (Upsher Smith Laboratories, Inc.)
        8.3.10 Perampanel (Eisai Co) 
        8.3.11 YKP3089 (SK Life Sciences) 
9. Antiepileptic Drugs Market– By Route of Administration (Market Size -$Million/$Billion)
    9.1 Oral
    9.2 Intravenous
10. Antiepileptic Drugs Market– By Spectrum Type (Market Size -$Million/$Billion)
    10.1 Narrow Spectrum
    10.2 Broad Spectrum
11. Antiepileptic Drugs Market– By Distribution Channel (Market Size -$Million/$Billion)
    11.1 Hospital Pharmacies
    11.2 Retail Pharmacies
    11.3 Online Pharmacies
12. Antiepileptic Drugs Market- By Geography (Market Size -$Million/$Billion)
    12.1 North America
        12.1.1 U.S.
        12.1.2 Canada
        12.1.3 Mexico
    12.2 Europe
        12.2.1 U.K.
        12.2.2 Germany
        12.2.3 France
        12.2.4 Italy
        12.2.5 Spain
        12.2.6 Rest of Europe
    12.3 Asia-Pacific
        12.3.1 China
        12.3.2 Japan
        12.3.3 South Korea
        12.3.4 India
        12.3.5 Australia & New Zealand
        12.3.6 Rest of Asia-Pacific
    12.4 Rest of the World
        12.4.1 Middle East
        12.4.2 Africa
        12.4.3 South America
13. Antiepileptic Drugs Market Entropy
14. Antiepileptic Drugs Market - Industry / Segment Competition landscape Premium Premium
    14.1 Market Share Analysis
        14.1.1 Market Share by Country- Key companies
        14.1.2 Market Share by Region- Key companies
        14.1.3 Market Share at Global Level- Key companies
        14.1.4 Best Practices for Companies
15. Antiepileptic Drugs Market- Key Company List by Country Premium Premium
16. Antiepileptic Drugs Market Company Analysis
    16.1 Company Revenue, Products, M&A, Developments
    16.2 Company 1
    16.3 Company 2
    16.4 Company 3
    16.5 Company 4
    16.6 Company 5
    16.7 Company 6
    16.8 Company 7
    16.9 Company 8
    16.10 Company 9
    16.11 Company 10
"*Financials for private companies would be provided on a best efforts basis”.
List of Tables
Table 1: Antiepileptic Drugs Market Overview 2021-2026
Table 2: Antiepileptic Drugs Market Leader Analysis 2018-2019 (US$)
Table 3: Antiepileptic Drugs Market Product Analysis 2018-2019 (US$)
Table 4: Antiepileptic Drugs Market End User Analysis 2018-2019 (US$)
Table 5: Antiepileptic Drugs Market Patent Analysis 2013-2018* (US$)
Table 6: Antiepileptic Drugs Market Financial Analysis 2018-2019 (US$)
Table 7: Antiepileptic Drugs Market Driver Analysis 2018-2019 (US$)
Table 8: Antiepileptic Drugs Market Challenges Analysis 2018-2019 (US$)
Table 9: Antiepileptic Drugs Market Constraint Analysis 2018-2019 (US$)
Table 10: Antiepileptic Drugs Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: Antiepileptic Drugs Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: Antiepileptic Drugs Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: Antiepileptic Drugs Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: Antiepileptic Drugs Market Degree of Competition Analysis 2018-2019 (US$)
Table 15: Antiepileptic Drugs Market Value Chain Analysis 2018-2019 (US$)
Table 16: Antiepileptic Drugs Market Pricing Analysis 2021-2026 (US$)
Table 17: Antiepileptic Drugs Market Opportunities Analysis 2021-2026 (US$)
Table 18: Antiepileptic Drugs Market Product Life Cycle Analysis 2021-2026 (US$)
Table 19: Antiepileptic Drugs Market Supplier Analysis 2018-2019 (US$)
Table 20: Antiepileptic Drugs Market Distributor Analysis 2018-2019 (US$)
Table 21: Antiepileptic Drugs Market Trend Analysis 2018-2019 (US$)
Table 22: Antiepileptic Drugs Market Size 2018 (US$)
Table 23: Antiepileptic Drugs Market Forecast Analysis 2021-2026 (US$)
Table 24: Antiepileptic Drugs Market Sales Forecast Analysis 2021-2026 (Units)
Table 25: Antiepileptic Drugs Market, Revenue & Volume,By Type, 2021-2026 ($)
Table 26: Antiepileptic Drugs Market By Type, Revenue & Volume,By First Generation Drugs, 2021-2026 ($)
Table 27: Antiepileptic Drugs Market By Type, Revenue & Volume,By Second Generation Drugs, 2021-2026 ($)
Table 28: Antiepileptic Drugs Market By Type, Revenue & Volume,By Pipeline Drugs, 2021-2026 ($)
Table 29: North America Antiepileptic Drugs Market, Revenue & Volume,By Type, 2021-2026 ($)
Table 30: South america Antiepileptic Drugs Market, Revenue & Volume,By Type, 2021-2026 ($)
Table 31: Europe Antiepileptic Drugs Market, Revenue & Volume,By Type, 2021-2026 ($)
Table 32: APAC Antiepileptic Drugs Market, Revenue & Volume,By Type, 2021-2026 ($)
Table 33: Middle East & Africa Antiepileptic Drugs Market, Revenue & Volume,By Type, 2021-2026 ($)
Table 34: Russia Antiepileptic Drugs Market, Revenue & Volume,By Type, 2021-2026 ($)
Table 35: Israel Antiepileptic Drugs Market, Revenue & Volume,By Type, 2021-2026 ($)
Table 36: Top Companies 2018 (US$)Antiepileptic Drugs Market, Revenue & Volume
Table 37: Product Launch 2018-2019Antiepileptic Drugs Market, Revenue & Volume
Table 38: Mergers & Acquistions 2018-2019Antiepileptic Drugs Market, Revenue & Volume

List of Figures
Figure 1: Overview of Antiepileptic Drugs Market 2021-2026
Figure 2: Market Share Analysis for Antiepileptic Drugs Market 2018 (US$)
Figure 3: Product Comparison in Antiepileptic Drugs Market 2018-2019 (US$)
Figure 4: End User Profile for Antiepileptic Drugs Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Antiepileptic Drugs Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Antiepileptic Drugs Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Antiepileptic Drugs Market 2018-2019
Figure 8: Ecosystem Analysis in Antiepileptic Drugs Market 2018
Figure 9: Average Selling Price in Antiepileptic Drugs Market 2021-2026
Figure 10: Top Opportunites in Antiepileptic Drugs Market 2018-2019
Figure 11: Market Life Cycle Analysis in Antiepileptic Drugs Market
Figure 12: GlobalBy TypeAntiepileptic Drugs Market Revenue, 2021-2026 ($)
Figure 13: Global Antiepileptic Drugs Market - By Geography
Figure 14: Global Antiepileptic Drugs Market Value & Volume, By Geography, 2021-2026 ($) 
Figure 15: Global Antiepileptic Drugs Market CAGR, By Geography, 2021-2026 (%)
Figure 16: North America Antiepileptic Drugs Market Value & Volume, 2021-2026 ($)
Figure 17: US Antiepileptic Drugs Market Value & Volume, 2021-2026 ($)
Figure 18: US GDP and Population, 2018-2019 ($)
Figure 19: US GDP – Composition of 2018, By Sector of Origin
Figure 20: US Export and Import Value & Volume, 2018-2019 ($)
Figure 21: Canada Antiepileptic Drugs Market Value & Volume, 2021-2026 ($)
Figure 22: Canada GDP and Population, 2018-2019 ($)
Figure 23: Canada GDP – Composition of 2018, By Sector of Origin
Figure 24: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 25: Mexico Antiepileptic Drugs Market Value & Volume, 2021-2026 ($)
Figure 26: Mexico GDP and Population, 2018-2019 ($)
Figure 27: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 28: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 29: South America Antiepileptic Drugs Market Value & Volume, 2021-2026 ($)
Figure 30: Brazil Antiepileptic Drugs Market Value & Volume, 2021-2026 ($)
Figure 31: Brazil GDP and Population, 2018-2019 ($)
Figure 32: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 33: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 34: Venezuela Antiepileptic Drugs Market Value & Volume, 2021-2026 ($)
Figure 35: Venezuela GDP and Population, 2018-2019 ($)
Figure 36: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 37: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 38: Argentina Antiepileptic Drugs Market Value & Volume, 2021-2026 ($)
Figure 39: Argentina GDP and Population, 2018-2019 ($)
Figure 40: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 41: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 42: Ecuador Antiepileptic Drugs Market Value & Volume, 2021-2026 ($)
Figure 43: Ecuador GDP and Population, 2018-2019 ($)
Figure 44: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 45: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 46: Peru Antiepileptic Drugs Market Value & Volume, 2021-2026 ($)
Figure 47: Peru GDP and Population, 2018-2019 ($)
Figure 48: Peru GDP – Composition of 2018, By Sector of Origin
Figure 49: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 50: Colombia Antiepileptic Drugs Market Value & Volume, 2021-2026 ($)
Figure 51: Colombia GDP and Population, 2018-2019 ($)
Figure 52: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 53: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 54: Costa Rica Antiepileptic Drugs Market Value & Volume, 2021-2026 ($)
Figure 55: Costa Rica GDP and Population, 2018-2019 ($)
Figure 56: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 57: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 58: Europe Antiepileptic Drugs Market Value & Volume, 2021-2026 ($)
Figure 59: U.K Antiepileptic Drugs Market Value & Volume, 2021-2026 ($)
Figure 60: U.K GDP and Population, 2018-2019 ($)
Figure 61: U.K GDP – Composition of 2018, By Sector of Origin
Figure 62: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 63: Germany Antiepileptic Drugs Market Value & Volume, 2021-2026 ($)
Figure 64: Germany GDP and Population, 2018-2019 ($)
Figure 65: Germany GDP – Composition of 2018, By Sector of Origin
Figure 66: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 67: Italy Antiepileptic Drugs Market Value & Volume, 2021-2026 ($)
Figure 68: Italy GDP and Population, 2018-2019 ($)
Figure 69: Italy GDP – Composition of 2018, By Sector of Origin
Figure 70: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 71: France Antiepileptic Drugs Market Value & Volume, 2021-2026 ($)
Figure 72: France GDP and Population, 2018-2019 ($)
Figure 73: France GDP – Composition of 2018, By Sector of Origin
Figure 74: France Export and Import Value & Volume, 2018-2019 ($)
Figure 75: Netherlands Antiepileptic Drugs Market Value & Volume, 2021-2026 ($)
Figure 76: Netherlands GDP and Population, 2018-2019 ($)
Figure 77: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 78: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 79: Belgium Antiepileptic Drugs Market Value & Volume, 2021-2026 ($)
Figure 80: Belgium GDP and Population, 2018-2019 ($)
Figure 81: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 82: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 83: Spain Antiepileptic Drugs Market Value & Volume, 2021-2026 ($)
Figure 84: Spain GDP and Population, 2018-2019 ($)
Figure 85: Spain GDP – Composition of 2018, By Sector of Origin
Figure 86: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 87: Denmark Antiepileptic Drugs Market Value & Volume, 2021-2026 ($)
Figure 88: Denmark GDP and Population, 2018-2019 ($)
Figure 89: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 90: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 91: APAC Antiepileptic Drugs Market Value & Volume, 2021-2026 ($)
Figure 92: China Antiepileptic Drugs Market Value & Volume, 2021-2026
Figure 93: China GDP and Population, 2018-2019 ($)
Figure 94: China GDP – Composition of 2018, By Sector of Origin
Figure 95: China Export and Import Value & Volume, 2018-2019 ($)Antiepileptic Drugs Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 96: Australia Antiepileptic Drugs Market Value & Volume, 2021-2026 ($)
Figure 97: Australia GDP and Population, 2018-2019 ($)
Figure 98: Australia GDP – Composition of 2018, By Sector of Origin
Figure 99: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 100: South Korea Antiepileptic Drugs Market Value & Volume, 2021-2026 ($)
Figure 101: South Korea GDP and Population, 2018-2019 ($)
Figure 102: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 103: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 104: India Antiepileptic Drugs Market Value & Volume, 2021-2026 ($)
Figure 105: India GDP and Population, 2018-2019 ($)
Figure 106: India GDP – Composition of 2018, By Sector of Origin
Figure 107: India Export and Import Value & Volume, 2018-2019 ($)
Figure 108: Taiwan Antiepileptic Drugs Market Value & Volume, 2021-2026 ($)
Figure 109: Taiwan GDP and Population, 2018-2019 ($)
Figure 110: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 111: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 112: Malaysia Antiepileptic Drugs Market Value & Volume, 2021-2026 ($)
Figure 113: Malaysia GDP and Population, 2018-2019 ($)
Figure 114: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 115: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 116: Hong Kong Antiepileptic Drugs Market Value & Volume, 2021-2026 ($)
Figure 117: Hong Kong GDP and Population, 2018-2019 ($)
Figure 118: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 119: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 120: Middle East & Africa Antiepileptic Drugs Market Middle East & Africa 3D Printing Market Value & Volume, 2021-2026 ($)
Figure 121: Russia Antiepileptic Drugs Market Value & Volume, 2021-2026 ($)
Figure 122: Russia GDP and Population, 2018-2019 ($)
Figure 123: Russia GDP – Composition of 2018, By Sector of Origin
Figure 124: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 125: Israel Antiepileptic Drugs Market Value & Volume, 2021-2026 ($)
Figure 126: Israel GDP and Population, 2018-2019 ($)
Figure 127: Israel GDP – Composition of 2018, By Sector of Origin
Figure 128: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 129: Entropy Share, By Strategies, 2018-2019* (%)Antiepileptic Drugs Market 
Figure 130: Developments, 2018-2019*Antiepileptic Drugs Market 
Figure 131: Company 1 Antiepileptic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 132: Company 1 Antiepileptic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 133: Company 1 Antiepileptic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 134: Company 2 Antiepileptic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 135: Company 2 Antiepileptic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 136: Company 2 Antiepileptic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 137: Company 3Antiepileptic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 138: Company 3Antiepileptic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 139: Company 3Antiepileptic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 140: Company 4 Antiepileptic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 141: Company 4 Antiepileptic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 142: Company 4 Antiepileptic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 143: Company 5 Antiepileptic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 144: Company 5 Antiepileptic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 145: Company 5 Antiepileptic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 146: Company 6 Antiepileptic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 147: Company 6 Antiepileptic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 148: Company 6 Antiepileptic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 149: Company 7 Antiepileptic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 150: Company 7 Antiepileptic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 151: Company 7 Antiepileptic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 152: Company 8 Antiepileptic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 153: Company 8 Antiepileptic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 154: Company 8 Antiepileptic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 155: Company 9 Antiepileptic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 156: Company 9 Antiepileptic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 157: Company 9 Antiepileptic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 158: Company 10 Antiepileptic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 159: Company 10 Antiepileptic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 160: Company 10 Antiepileptic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 161: Company 11 Antiepileptic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 162: Company 11 Antiepileptic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 163: Company 11 Antiepileptic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 164: Company 12 Antiepileptic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 165: Company 12 Antiepileptic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 166: Company 12 Antiepileptic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 167: Company 13Antiepileptic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 168: Company 13Antiepileptic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 169: Company 13Antiepileptic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 170: Company 14 Antiepileptic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 171: Company 14 Antiepileptic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 172: Company 14 Antiepileptic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 173: Company 15 Antiepileptic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 174: Company 15 Antiepileptic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 175: Company 15 Antiepileptic Drugs Market Net Sales Share, By Geography, 2018 (%)